Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

CUP: looking for a missing primary site and its biology.

Pentheroudakis G.

Ann Oncol. 2012 Sep;23 Suppl 10:x278-81. No abstract available.

PMID:
22987976
2.
3.

Practical Applications in Immunohistochemistry: Carcinomas of Unknown Primary Site.

Kandalaft PL, Gown AM.

Arch Pathol Lab Med. 2016 Jun;140(6):508-23. doi: 10.5858/arpa.2015-0173-CP. Epub 2015 Oct 12.

PMID:
26457625
4.

Cancer of unknown primary site: still an entity, a biological mystery and a metastatic model.

Greco FA.

Nat Rev Cancer. 2014 Jan;14(1):3-4. No abstract available.

PMID:
24505613
5.

[Peritoneal carcinomatosis of unknown origin].

Marchal N, Gennigens C, Jerusalem G.

Rev Med Liege. 2012 Nov;67(11):582-6. Review. French.

PMID:
23346828
6.

Anaplastic large-cell lymphoma with aberrant expression of multiple cytokeratins masquerading as metastatic carcinoma of unknown primary.

Nguyen TT, Kreisel FH, Frater JL, Bartlett NL.

J Clin Oncol. 2013 Nov 20;31(33):e443-5. doi: 10.1200/JCO.2012.46.7910. Epub 2013 Jun 17. No abstract available.

PMID:
23775969
7.
8.

[Diagnostic management of inaugurable metastases].

Penel N.

Presse Med. 2003 Jun 14;32(21):990-6, 1004. Review. French.

PMID:
12876530
9.

Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.

Greco FA.

Curr Treat Options Oncol. 2013 Dec;14(4):634-42. doi: 10.1007/s11864-013-0257-1. Review.

PMID:
23990214
11.

Diagnostic evaluation of patients with carcinoma of unknown primary tumor site.

Leonard RJ, Nystrom JS.

Semin Oncol. 1993 Jun;20(3):244-50. Review. No abstract available.

PMID:
8503020
12.

Cutaneous metastases carcinoma. Case report and pathological considerations.

Costache M, Simionescu O, Sajin M, Chefani A.

Rom J Morphol Embryol. 2007;48(2):177-80.

13.

A microarray-based gene expression analysis to identify diagnostic biomarkers for unknown primary cancer.

Kurahashi I, Fujita Y, Arao T, Kurata T, Koh Y, Sakai K, Matsumoto K, Tanioka M, Takeda K, Takiguchi Y, Yamamoto N, Tsuya A, Matsubara N, Mukai H, Minami H, Chayahara N, Yamanaka Y, Miwa K, Takahashi S, Takahashi S, Nakagawa K, Nishio K.

PLoS One. 2013 May 9;8(5):e63249. doi: 10.1371/journal.pone.0063249. Print 2013.

14.

Metastatic malignant disease of unknown primary site--a clinical analysis of sixty eight cases.

Ng KT, Liaw CC, Huang CH, Huang JS, Wang JM.

Changgeng Yi Xue Za Zhi. 1987 Sep 20;10(3):232-8. No abstract available.

PMID:
3455293
15.

[Comparing immunohistochemical diagnosis of cancer of unknown primary with gene expression-based tumor classification].

Morawietz L, Floore A, Stork-Sloots L, Folprecht G, Buettner R, Rieger A, Dietel M, Huebner G.

Pathologe. 2009 Dec;30 Suppl 2:168-72. doi: 10.1007/s00292-009-1194-4. German.

PMID:
19756615
16.

Cancer of unknown primary site: missing primary or missing biology?

Pentheroudakis G, Briasoulis E, Pavlidis N.

Oncologist. 2007 Apr;12(4):418-25. Review.

17.

[Diagnostic approach to cancer of unknown primary site].

Fernández Cotarelo MJ, Guerra Vales JM.

Rev Clin Esp. 2009 Jul-Aug;209(7):347-51. Spanish.

PMID:
19709540
18.

Emerin expression in well differentiated epithelial lesions of thyroid: implications in papillary thyroid carcinoma diagnosis and predicting malignant behavior.

Coban I, Cakir A, Unal TD, Bassullu N, Karpuz V, Dogusoy GB, Alper M.

Pathol Oncol Res. 2015 Apr;21(2):357-66. doi: 10.1007/s12253-014-9828-0. Epub 2014 Aug 14.

PMID:
25116851
19.

Immunocytochemical identification of carcinomas of unknown primary in serous effusions.

Pomjanski N, Grote HJ, Doganay P, Schmiemann V, Buckstegge B, Böcking A.

Diagn Cytopathol. 2005 Nov;33(5):309-15.

PMID:
16240395
20.

Discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the 'self (stem cell)-seeding' nature of breast cancer disease?

Lopez-Bonet E, Menendez JA.

Ann Oncol. 2010 Apr;21(4):901-2. doi: 10.1093/annonc/mdp579. Epub 2009 Dec 23. No abstract available.

PMID:
20032125

Supplemental Content

Support Center